AI Is Making Claim Denials Worse for Physician Practices. Here’s Why

Why It Matters

The surge in AI‑driven denials erodes practice revenue and forces clinicians to allocate valuable time to appeals, threatening both financial health and patient care efficiency. Understanding and adapting to these automated systems is now essential for revenue‑cycle resilience.

Key Takeaways

• Denial rates exceed 10% for 41% of providers, up from 30% in 2022
• Average inpatient denial amount rose 12% YoY; outpatient rose 14%
• Medicare Advantage generated 53 M prior authorizations in 2024, denying 7.7%
• Physicians spend ~13 hours weekly on prior authorizations, 39 requests per doctor
• 80% of appealed MA denials are overturned, showing many are reversible

Pulse Analysis

The integration of artificial intelligence into payer claim‑review platforms promises speed and consistency, yet recent data reveal a paradox: denial rates are climbing across the United States. Experian Health’s State of Claims 2025 survey indicates that 41% of providers now experience denial rates above 10%, a noticeable jump from 30% just two years ago. Simultaneously, MDaudit’s 2025 Benchmark Report shows denied inpatient claim amounts up 12% and outpatient amounts up 14% year over year, with the average cost per denial soaring to $450. These figures underscore a systemic shift where automated algorithms enforce increasingly granular documentation and coding standards, catching errors that previously slipped through manual reviews.

The impact is most acute for practices with large Medicare Advantage panels. KFF reports that insurers processed 53 million prior‑authorization requests in 2024, denying 4.1 million (7.7%). Although 80% of appealed denials are eventually overturned, the initial denial triggers extensive follow‑up work—resubmissions, peer‑to‑peer reviews, and additional documentation. The AMA’s 2024 survey quantifies this burden: each physician handles roughly 39 prior‑authorization requests per week, consuming about 13 hours of staff time. This administrative drag not only delays cash flow but also diverts clinicians from patient care, amplifying the cost of AI‑driven denial management.

While regulatory reforms—such as the 2025 voluntary prior‑authorization pledge and CMS transparency rules—aim to curb excesses, most practices must rely on internal process upgrades. Proactive strategies include tracking payer‑specific denial metrics, moving authorization steps upstream in the scheduling workflow, and standardizing documentation to meet both clinical and algorithmic criteria. By leveraging detailed denial‑reason analytics and maintaining a real‑time policy‑change watch, practices can anticipate payer expectations and reduce avoidable denials. In the near term, sophisticated revenue‑cycle management, whether in‑house or outsourced, will be the decisive factor in safeguarding reimbursement amid an increasingly automated claims landscape.